Oxycodone Hydrochloride Wockhardt Uk

Oxycodone Hydrochloride, the active ingredient in Oxycodone Hydrochloride Wockhardt Uk, is an opioid analgesic presented as an oral tablet for oral use. It is prescribed to manage moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxycodone Hydrochloride Wockhardt Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid analgesic used in the management of moderate to severe pain.

- Acute postoperative pain: provides rapid relief after surgical procedures. - Cancer‑related pain: controls persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: alleviates long‑term pain when alternative therapies are inadequate.

Oxycodone Hydrochloride may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Dry mouth - Vomiting

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Seizures - Allergic reactions (rash, angioedema) - Dependence or addiction - Adrenal insufficiency

When prescribing Oxycodone Hydrochloride, clinicians should observe several safety measures.

- Assess pain severity and treatment goals before initiating therapy. - Evaluate patient history for respiratory disorders such as COPD or sleep apnea. - Monitor for signs of dependence, tolerance, or misuse throughout treatment. - Avoid use in patients with severe hepatic impairment unless benefits outweigh risks. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Oxycodone Hydrochloride interacts with several drug classes that may alter its safety or efficacy.

Major Interactions (Avoid): - Concomitant use with other opioids: increased risk of respiratory depression. - Benzodiazepines or other CNS depressants: synergistic sedation and respiratory effects. - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may raise oxycodone plasma concentrations. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect. - Anticholinergic agents: can exacerbate constipation.